These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 9925665)
1. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Calabresi L; Franceschini G; Sirtori CR; De Palma A; Saresella M; Ferrante P; Taramelli D Biochem Biophys Res Commun; 1997 Sep; 238(1):61-5. PubMed ID: 9299452 [TBL] [Abstract][Full Text] [Related]
3. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ J Lipid Res; 2000 Aug; 41(8):1261-7. PubMed ID: 10946014 [TBL] [Abstract][Full Text] [Related]
4. Lack of inhibitory effect of HDL on TNFalpha-induced adhesion molecule expression in human aortic endothelial cells. Zhang WJ; Stocker R; McCall MR; Forte TM; Frei B Atherosclerosis; 2002 Dec; 165(2):241-9. PubMed ID: 12417274 [TBL] [Abstract][Full Text] [Related]
5. Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins. Clay MA; Pyle DH; Rye KA; Vadas MA; Gamble JR; Barter PJ Atherosclerosis; 2001 Jul; 157(1):23-9. PubMed ID: 11427200 [TBL] [Abstract][Full Text] [Related]
6. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Ashby DT; Rye KA; Clay MA; Vadas MA; Gamble JR; Barter PJ Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1450-5. PubMed ID: 9743234 [TBL] [Abstract][Full Text] [Related]
7. Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression. Ashby D; Gamble J; Vadas M; Fidge N; Siggins S; Rye K; Barter PJ Atherosclerosis; 2001 Jan; 154(1):113-21. PubMed ID: 11137089 [TBL] [Abstract][Full Text] [Related]
8. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein. Settasatian N; Barter PJ; Rye KA J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435 [TBL] [Abstract][Full Text] [Related]
9. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase. Clay MA; Pyle DH; Rye KA; Barter PJ J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751 [TBL] [Abstract][Full Text] [Related]
10. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit. Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA Lipids Health Dis; 2011 Nov; 10():224. PubMed ID: 22128776 [TBL] [Abstract][Full Text] [Related]
12. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling. Rye KA; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter PJ Biochemistry; 2002 Oct; 41(41):12538-45. PubMed ID: 12369845 [TBL] [Abstract][Full Text] [Related]
13. High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1. Wu BJ; Chen K; Shrestha S; Ong KL; Barter PJ; Rye KA Circ Res; 2013 Jan; 112(2):278-88. PubMed ID: 23123430 [TBL] [Abstract][Full Text] [Related]
14. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025 [TBL] [Abstract][Full Text] [Related]
15. Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit. Hime NJ; Drew KJ; Wee K; Barter PJ; Rye KA J Lipid Res; 2006 Jan; 47(1):115-22. PubMed ID: 16222033 [TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275 [TBL] [Abstract][Full Text] [Related]
17. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. Rye KA; Hime NJ; Barter PJ J Biol Chem; 1996 Feb; 271(8):4243-50. PubMed ID: 8626769 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory functions of apolipoprotein A-I and high-density lipoprotein are preserved in trimeric apolipoprotein A-I. Murphy AJ; Hoang A; Aprico A; Sviridov D; Chin-Dusting J J Pharmacol Exp Ther; 2013 Jan; 344(1):41-9. PubMed ID: 23033374 [TBL] [Abstract][Full Text] [Related]
19. The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins. Rye KA; Hime NJ; Barter PJ J Biol Chem; 1995 Jan; 270(1):189-96. PubMed ID: 7814372 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]